false000168037800016803782026-11-162026-11-17
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 16, 2026
SenesTech, Inc.
(Exact name of registrant as specified in its charter)
| | | | | | | | | | | | | | |
| Delaware | | 001-37941 | | 20-2079805 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
| | | | | | | | |
13430 North Dysart Road, Suite 105 Surprise, AZ | | 85379 |
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (928) 779-4143
| | |
N/A |
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | | | | |
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
| Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
| Common Stock, $0.001 par value | | SNES | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 16, 2026, our Board of Directors (the “Board”) authorized an increase in the size of the Board to eight members and appointed JoAnna Abrams to serve on the Board as an independent director. Ms. Abrams will serve as a Class II director until the 2027 Annual Meeting of Stockholders or until her earlier death, resignation, or removal or until a successor is elected and qualified. Ms. Abrams was also appointed to serve as a member of the Commercialization Committee of the Board.
As a non-employee director, Ms. Abrams will receive compensation as described in the “Director Compensation” section of our 2026 Proxy Statement filed with the Securities and Exchange Commission on April 29, 2026.
There are no arrangements or understandings between Ms. Abrams and any other person pursuant to which Ms. Abrams was selected as a director. Ms. Abrams is not party to any transaction subject to Item 404(a) of Regulation S-K under the Securities Exchange Act of 1934, as amended, involving our company.
The Company issued a press release on November 17, 2026 announcing the appointment of Ms. Abrams to the Board. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits.
| | | | | | | | |
| Exhibit Number | | Description |
| 99.1 | | Press Release dated November 17, 2026 (furnished herewith). |
| 104 | | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | |
| Date: November 17, 2026 | SENESTECH, INC. |
| | |
| By: | /s/ Thomas C. Chesterman |
| | Thomas C. Chesterman |
| | Executive Vice President, Chief Financial Officer, Treasurer and Secretary |
SenesTech Appoints JoAnna Abrams to Board of Directors
Entrepreneur and consumer brand leader brings commercial expertise to the Board as consumer expectations reshape everyday pest management for homes and businesses
SURPRISE, Ariz., November 17, 2026 (GLOBE NEWSWIRE) — SenesTech, Inc. (NASDAQ: SNES), an innovator in responsible rodent population management, today announced the appointment of JoAnna Abrams to its Board of Directors, effective November 16, 2026. In connection with the appointment, the Board increased its size to eight members. The Company believes the appointment adds consumer-brand and commercial-market expertise to the Board as the Company focuses on profitable growth across its consumer and professional markets. Ms. Abrams will also serve on the Board’s Commercialization Committee. The Board has determined that she qualifies as an independent director under applicable Nasdaq listing standards.
“JoAnna brings commercial experience and a strong understanding of how price, product performance, and responsible practices influence purchasing decisions,” said Matthew Szot, chairman of SenesTech’s Board of Directors. “We believe her experience building brands will be valuable to our Board and Commercialization Committee as we work to expand customer adoption and translate revenue growth into improved profitability.”
Ms. Abrams is an entrepreneur and consumer-brand leader with more than two decades of experience in how health-conscious demand moves from households to businesses. At PepsiCo, Nestlé and Toyota, she launched products across retail, food service and B2B channels. As founder and CEO of Mindclick, the Product Intelligence™ company, she pioneered supply chain product ratings with Marriott International and now guides purchasing on more than 150,000 products for leading hospitality, real estate and healthcare organizations.
Ms. Abrams was named to Inc.’s 2026 Female Founders 500 and is an IMAGINE Leader in the global CEO community co-founded by former Unilever CEO Paul Polman. She holds an MBA from Harvard Business School and a BS in Finance from the University of Illinois.
“Pest management is a challenge every home and business faces, in a category where I believe expectations for responsible solutions are rising.” said Ms. Abrams. “I believe SenesTech is well positioned for that shift, and I look forward to working with my fellow directors and the management team to build long-term value for stockholders.”
About SenesTech
SenesTech, Inc. (NASDAQ: SNES) is advancing the future of rodent control and integrated pest management (IPM). Its products deliver long-term control of rodent populations by limiting reproduction, complementing the sanitation, exclusion, monitoring and targeted removal tools that make up modern IPM programs, as regulations and customer expectations move the industry toward more responsible approaches. The Company serves consumer and professional markets through Evolve®, an easy-to-use soft bait, and ContraPest®, a liquid formulation for professional pest management, along with assessment and monitoring services that help customers measure results.
For more information, visit www.senestech.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding the Company’s growth opportunities, commercial expansion, market adoption and expected benefits of the appointment of Ms. Abrams to the Board of Directors. Such forward-looking statements include, among others, our belief that the appointment of Ms. Abrams adds consumer-brand and commercial-market expertise to the Board as the Company focuses on profitable growth across its consumer and professional markets; our belief that Ms. Abrams’ experience building brands will be valuable to our Board and Commercialization Committee as we work to expand customer adoption and translate revenue growth into improved profitability; the belief that expectations for responsible solutions in the pest management category are rising; the belief that SenesTech is well positioned for the shift of rising expectations for responsible solutions; and the expectation that Ms. Abrams will work with her fellow directors and the management team to build long-term value for stockholders. These statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Such risks and uncertainties include those described in SenesTech’s filings with the Securities and Exchange Commission. SenesTech undertakes no obligation to update these forward-looking statements except as required by law.
Contacts
Investor Contact:
Robert Blum, Lytham Partners, LLC
(602) 889-9700, senestech@lythampartners.com
Company Contact:
Tom Chesterman, SenesTech, Inc.
(928) 233-7533, investors@senestech.com